Featured News - 2019 Archives

December 5, 2019
The company that makes aducanumab for Alzheimer's disease says that the drug slows mental decline. Biogen Inc. revealed its new analyses of data from its phase 3[...]

March 4, 2019

March 4, 2019

February 28, 2019

February 28, 2019

February 28, 2019

February 28, 2019
Explore more topics
Sign up

Mayo Clinic Connect
An online patient support community